cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA.
about
Molecular biology of hepatitis B virus infectionIncorporation of eukaryotic translation initiation factor eIF4E into viral nucleocapsids via interaction with hepatitis B virus polymerase.Effects of genomic length on translocation of hepatitis B virus polymerase-linked oligomer.Properties of monoclonal antibodies directed against hepatitis B virus polymerase protein.Mapping of the hepatitis B virus reverse transcriptase TP and RT domains by transcomplementation for nucleotide priming and by protein-protein interactionThe duck hepatitis B virus polymerase is activated by its RNA packaging signal, epsilon.In vitro reconstitution of a functional duck hepatitis B virus reverse transcriptase: posttranslational activation by Hsp90.Interaction between hepatitis B virus core protein and reverse transcriptase.Human hepatitis B virus polymerase interacts with the molecular chaperonin Hsp60.Sequences in the terminal protein and reverse transcriptase domains of the hepatitis B virus polymerase contribute to RNA binding and encapsidationHepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids.A SELEX-screened aptamer of human hepatitis B virus RNA encapsidation signal suppresses viral replication.A novel cis-acting element facilitates minus-strand DNA synthesis during reverse transcription of the hepatitis B virus genome.In vitro reconstitution of functional hepadnavirus reverse transcriptase with cellular chaperone proteins.cis-Acting sequences that contribute to synthesis of minus-strand DNA are not conserved between hepadnaviruses.Hepatitis B virus reverse transcriptase and epsilon RNA sequences required for specific interaction in vitro.Interactions between Sindbis virus RNAs and a 68 amino acid derivative of the viral capsid protein further defines the capsid binding site.RNA elements directing translation of the duck hepatitis B Virus polymerase via ribosomal shunting.Three novel cis-acting elements required for efficient plus-strand DNA synthesis of the hepatitis B virus genome.Hepadnavirus Genome Replication and Persistence.Mutations in the epsilon sequences of human hepatitis B virus affect both RNA encapsidation and reverse transcriptionIllegitimate replication of linear hepadnavirus DNA through nonhomologous recombinationNucleotide priming and reverse transcriptase activity of hepatitis B virus polymerase expressed in insect cellsDuck hepatitis B virus polymerase acts as a suppressor of core protein translationTranscomplementation of nucleotide priming and reverse transcription between independently expressed TP and RT domains of the hepatitis B virus reverse transcriptase.Effects of mutations within and adjacent to the terminal repeats of hepatitis B virus pregenomic RNA on viral DNA synthesisSequence-independent RNA cleavages generate the primers for plus strand DNA synthesis in hepatitis B viruses: implications for other reverse transcribing elements.In vitro epsilon RNA-dependent protein priming activity of human hepatitis B virus polymerase.Hepatic deficiency of the pioneer transcription factor FoxA restricts hepatitis B virus biosynthesis by the developmental regulation of viral DNA methylationCapsid assembly and involved function analysis of twelve core protein mutants of duck hepatitis B viruspet, a small sequence distal to the pregenome cap site, is required for expression of the duck hepatitis B virus pregenome.Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis.An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation.Evidence for a base-paired region of hepatitis B virus pregenome encapsidation signal which influences the patterns of precore mutations abolishing HBe protein expression.Characterization of hepatitis B virus capsid particle assembly in Xenopus oocytes.RNA-protein interactions in hepadnavirus reverse transcription.trans-Complementation of HBV rtM204I mutant replication by HBV wild-type polymerase.Pre-P is a secreted glycoprotein encoded as an N-terminal extension of the duck hepatitis B virus polymerase gene.Comparative analysis of hepatitis B virus polymerase sequences required for viral RNA binding, RNA packaging, and protein priming.Residues Arg703, Asp777, and Arg781 of the RNase H domain of hepatitis B virus polymerase are critical for viral DNA synthesis.
P2860
Q28083478-B58388EE-62E8-499D-88F8-439DC850D45DQ33558760-5356A05D-C565-4326-B7D0-930D0E61F6F3Q33604337-8DF42094-BA75-4C7C-ADB6-A2DCAFF94C75Q33647709-1FFFCCF0-0FE0-4F25-AE88-9DE8D0CACF7FQ33652843-B194D336-B3FC-489F-83E7-27517A405879Q33785615-E1AC8CED-4B4E-4249-8A2C-4219DD66F4A0Q33812161-72B31896-2CBA-4616-B9B9-66444A252400Q33812219-F2170477-E48A-4A21-B26B-0BB1301DCD75Q33844349-6E9843A5-F97D-4B12-AA10-F70E9839C827Q33875691-8BED9C05-0D57-4EA9-8E9D-3413C468AE3FQ33885913-806D449A-02BE-4F21-9DD6-8FE9E2738932Q34085801-D4FD88F6-8DC4-40CF-852A-74A2E37D69BEQ34186351-0A346FC1-EC07-489B-B988-E695C626673CQ34327359-E4AD5282-5B0B-4DF9-B33E-199559B55D94Q34416515-1DF86953-7CF2-43ED-ADDD-6CCDF422273DQ34434801-2C5869AE-CF52-421A-B4FD-A4BBB940D335Q34808708-E1E59D40-5E79-48E3-8254-4D63D46AD461Q35077468-B1BFD502-42C5-44BF-A9CA-41E0B1FBADEBQ35122346-1D767265-2306-4D8B-A661-100A4B6D979CQ35795545-CBDBAD2A-5A29-4257-AF45-3F11E80F0706Q35839084-0018D48D-64CE-4AEA-92D3-5A6B9E5AAFA9Q35840746-F28793D6-E1AF-4FF2-8C58-7AC7F897BECEQ35841847-7CE60623-71F7-4EC9-9458-1714F5116B83Q35865800-CB9B3563-5015-45A0-B5E7-B22B62762DA9Q35880961-5F2E320D-164B-41DD-BCB4-FA20111F17DFQ35898446-1086608A-8AE0-470D-9064-BDEEA7AC8365Q35934278-445D1EF9-557A-4B38-B226-A4DA8AADE19CQ35943827-8A1364EF-B59F-48C3-AEB0-4C69D40BC464Q36290098-7815FCE0-0A08-4803-8F34-0AF082BD6A4FQ36619847-A5CAF980-D536-4980-99A4-E5DBD24C4A2CQ36629024-61DE4CFE-3A5A-4871-8CC6-995BEC5F465AQ36634911-CC63F400-5A96-418C-A30B-E5D88FA3B01AQ36647511-30635185-E3B0-4707-8C40-C3AA4DEE4912Q36652470-B3E522E9-39F8-42FE-858F-A8EF618D82F2Q36697538-930A6C3C-0184-450C-B650-3D9680AB57FCQ36727768-9FD08E8F-C3B7-4550-9F66-260932736ADCQ36897030-3DBEB0EC-0A88-490A-BC98-EFF3B3CA73B8Q37051609-6F1C5315-CF8F-495A-AC86-BE3419D2127AQ37547293-1654C607-9021-43D1-9ED3-806A2E773265Q37547715-4BE1E0AE-2E7F-4942-B6D9-E99DF970FECA
P2860
cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA.
@ast
cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA.
@en
type
label
cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA.
@ast
cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA.
@en
prefLabel
cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA.
@ast
cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA.
@en
P2093
P2860
P1433
P1476
cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA.
@en
P2093
P2860
P304
P407
P50
P577
1991-06-01T00:00:00Z